Tauns Laboratories (TYO:197A) has withdrawn its application to shift to the Tokyo Stock Exchange's Prime Market, citing delays in the review process and the need to revise submitted materials, according to a Monday filing on the Tokyo Stock Exchange.
The company had submitted the application using the fiscal year ended June 2024 as its reference period, but now expects the Tokyo bourse will not approve it before its upcoming shareholder meeting in September.
Tauns said it still aims to pursue a move to the Prime Market and will reassess the timing.